Using CRISPR/Cas9 gene editing (23, 24), we generated human keratinocytes having the first exon of ATP2A2 disrupted and performed multiomics analysis, which revealed inhibition of the MAPK pathway as a treatment strategy for DD. Here, ATP2A2 is linked to dentin dysplasia.